ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Lilia M. Beauchamp, 86, died on Nov. 12, 2017, in Raleigh, N.C.
“Lilia, an employee of Burroughs Wellcome for 30 years, was the first Burroughs Wellcome chemist to synthesize the nucleoside acyclovir (Zovirax) for use against the herpes virus family. She is the inventor of valacyclovir (Valtrex). Lilia and several colleagues cofounded Krenitsky Pharmaceuticals. Her research at Krenitsky Pharmaceuticals led to a series of pyrimidines with neuroprotective activity. Lilia is a coauthor on numerous publications, and she is a coinventor on many patents. Lilia is remembered as a gentle-natured colleague but also as a chemist who exhibited impressive tenacity in accomplishing her synthesis goals.”—James L. Kelley, friend and colleague
Most recent title: principal chemist, Krenitsky Pharmaceuticals
Education: M.S., organic chemistry, Fordham University
Survivor: cousin, Jacqueline Bonaguide
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter